MedPath

A randomised clinical trial assessing the additional value of ovarian hyperstimulation in intrauterine insemination for couples with an abnormal post-coital test.

Completed
Conditions
Subfertility.
Registration Number
NL-OMON21145
Lead Sponsor
OFO-projectt.a.v. B.W. MolAcademic Medical CenterCenter of Reporductive medicine, H4-213Postbus 226601100 DD AmsterdamPhone: 0031205663857Fax: 0031206963489e-mail: ofoproject@amc.uva.nl or b.mol1@chello.nl
Brief Summary

Fertil Steril. 2007 Dec;88(6):1618-24. Epub 2007 Jun 11. <br> <br><br> Partly presented in an oral presentation at the Conjoint Annual Meeting of the American Societty for Reproductive Medicine and the Canadian Fertility and Andrology Society, ASRM/CFAS 2005, Montreal, Quebec, Canada.<br>

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
250
Inclusion Criteria

Couples were eligible if they had an abnormal PCT, either due to cervical hostility diagnosed by a well-timed, non-progressive PCT with normal semen parameters or due to a poor semen quality.
The spontaneous pregnancy chance in the next year, leaving the result of the PCT out of consideration, was < 30%.

Exclusion Criteria

All other subfertile couples.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary endpoint was ongoing pregnancy within three cycles of IUI. <br />Ongoing pregnancy was defined as the presence of foetal cardiac activity at transvaginal sonography at a gestational age of at least 12 weeks.
Secondary Outcome Measures
NameTimeMethod
Secondary endpoints were total number of clinical pregnancies, miscarriages and multiple pregnancies.
© Copyright 2025. All Rights Reserved by MedPath